Gene Polymorphism

  • IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus
    Ming Zhao, Yin Zhou, Bochen Zhu, Mengjie Wan, Tingting Jiang, Qiqun Tan, Yan Liu, Juqing Jiang, Shuaihantian Luo, Yixin Tan, Haijing Wu, Paul Renauer, Maria del Mar Ayala Gutiérrez, Maria Jesús Castillo Palma, Rafaela Ortega Castro, Concepción Fernández-Roldán, Enrique Raya, Raquel Faria, Claudia Carvalho, Marta E Alarcón-Riquelme, Zhongyuan Xiang, Jinwei Chen, Fen Li, Guanghui Ling, Hongjun Zhao, Xiangping Liao, Youkun Lin, Amr H Sawalha, Qianjin Lu
  • Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2)
    T Karaderi, S M Keidel, J J Pointon, L H Appleton, M A Brown, D M Evans, B P Wordsworth
  • Predicting the severity of joint damage in rheumatoid arthritis; the contribution of genetic factors
    Hanna W van Steenbergen, Roula Tsonaka, Tom WJ Huizinga, Saskia le Cessie, Annette HM van der Helm-van Mil
  • New insight on the Xq28 association with systemic sclerosis
    F David Carmona, M Carmen Cénit, Lina-Marcela Diaz-Gallo, Jasper C A Broen, Carmen P Simeón, Patricia E Carreira, José-Luis Callejas-Rubio, Vicente Fonollosa, Francisco J López-Longo, Miguel A González-Gay, Nicolas Hunzelmann, Gabriela Riemekasten, Torsten Witte, Alexander Kreuter, Jörg H W Distler, Rajan Madhok, Paul Shiels, Jacob M van Laar, Annemie J Schuerwegh, Madelon C Vonk, Alexandre E Voskuyl, Carmen Fonseca, Christopher P Denton, Ariane Herrick, Jane Worthington, Frank C Arnett, Filemon K Tan, Shervin Assassi, Timothy R D J Radstake, Maureen D Mayes, Javier Martín, Spanish Scleroderma Group
  • Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis
    Chikashi Terao, Takahisa Kawaguchi, Philippe Dieude, John Varga, Masataka Kuwana, Marie Hudson, Yasushi Kawaguchi, Marco Matucci-Cerinic, Koichiro Ohmura, Gabriela Riemekasten, Aya Kawasaki, Paolo Airo, Tetsuya Horita, Akira Oka, Eric Hachulla, Hajime Yoshifuji, Paola Caramaschi, Nicolas Hunzelmann, Murray Baron, Tatsuya Atsumi, Paul Hassoun, Takeshi Torii, Meiko Takahashi, Yasuharu Tabara, Masakazu Shimizu, Akiko Tochimoto, Naho Ayuzawa, Hidetoshi Yanagida, Hiroshi Furukawa, Shigeto Tohma, Minoru Hasegawa, Manabu Fujimoto, Osamu Ishikawa, Toshiyuki Yamamoto, Daisuke Goto, Yoshihide Asano, Masatoshi Jinnin, Hirahito Endo, Hiroki Takahashi, Kazuhiko Takehara, Shinichi Sato, Hironobu Ihn, Soumya Raychaudhuri, Katherine Liao, Peter Gregersen, Naoyuki Tsuchiya, Valeria Riccieri, Inga Melchers, Gabriele Valentini, Anne Cauvet, Maria Martinez, Tsuneyo Mimori, Fumihiko Matsuda, Yannick Allanore
  • Genetic variants in ANCA-associated vasculitis: a meta-analysis
    Chinar Rahmattulla, Antien L Mooyaart, Daphne van Hooven, Jan W Schoones, Jan A Bruijn, Olaf M Dekkers, European Vasculitis Genetics Consortium, Ingeborg M Bajema
  • Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand
    Anna L Gosling, James Boocock, Nicola Dalbeth, Jennie Harré Hindmarsh, Lisa K Stamp, Eli A Stahl, Hyon K Choi, Elizabeth A Matisoo-Smith, Tony R Merriman
  • Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis
    Yuta Kochi, Yoichiro Kamatani, Yuya Kondo, Akari Suzuki, Eiryo Kawakami, Ryosuke Hiwa, Yukihide Momozawa, Manabu Fujimoto, Masatoshi Jinnin, Yoshiya Tanaka, Takashi Kanda, Robert G Cooper, Hector Chinoy, Simon Rothwell, Janine A Lamb, Jiří Vencovský, Heřman Mann, Koichiro Ohmura, Keiko Myouzen, Kazuyoshi Ishigaki, Ran Nakashima, Yuji Hosono, Hiroto Tsuboi, Hidenaga Kawasumi, Yukiko Iwasaki, Hiroshi Kajiyama, Tetsuya Horita, Mariko Ogawa-Momohara, Akito Takamura, Shinichiro Tsunoda, Jun Shimizu, Keishi Fujio, Hirofumi Amano, Akio Mimori, Atsushi Kawakami, Hisanori Umehara, Tsutomu Takeuchi, Hajime Sano, Yoshinao Muro, Tatsuya Atsumi, Toshihide Mimura, Yasushi Kawaguchi, Tsuneyo Mimori, Atsushi Takahashi, Michiaki Kubo, Hitoshi Kohsaka, Takayuki Sumida, Kazuhiko Yamamoto
  • DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
    Juliana Imgenberg-Kreuz, Jonas Carlsson Almlöf, Dag Leonard, Andrei Alexsson, Gunnel Nordmark, Maija-Leena Eloranta, Solbritt Rantapää-Dahlqvist, Anders A Bengtsson, Andreas Jönsen, Leonid Padyukov, Iva Gunnarsson, Elisabet Svenungsson, Christopher Sjöwall, Lars Rönnblom, Ann-Christine Syvänen, Johanna K Sandling
  • Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
    Michael J Ombrello, Victoria L Arthur, Elaine F Remmers, Anne Hinks, Ioanna Tachmazidou, Alexei A Grom, Dirk Foell, Alberto Martini, Marco Gattorno, Seza Özen, Sampath Prahalad, Andrew S Zeft, John F Bohnsack, Norman T Ilowite, Elizabeth D Mellins, Ricardo Russo, Claudio Len, Maria Odete E Hilario, Sheila Oliveira, Rae S M Yeung, Alan M Rosenberg, Lucy R Wedderburn, Jordi Anton, Johannes-Peter Haas, Angela Rosen-Wolff, Kirsten Minden, Klaus Tenbrock, Erkan Demirkaya, Joanna Cobb, Elizabeth Baskin, Sara Signa, Emily Shuldiner, Richard H Duerr, Jean-Paul Achkar, M Ilyas Kamboh, Kenneth M Kaufman, Leah C Kottyan, Dalila Pinto, Stephen W Scherer, Marta E Alarcón-Riquelme, Elisa Docampo, Xavier Estivill, Ahmet Gül, British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group, Carl D Langefeld, Susan Thompson, Eleftheria Zeggini, Daniel L Kastner, Patricia Woo, Wendy Thomson

Pages